1.
Lee S-E, Choi SY, Song H-Y, Kim S-H, Choi M-Y, Park JS, Kim H-J, Kim S-H, Zang DY, Oh S, Kim H, Do YR, Kwak J-Y, Kim J-A, Kim D-Y, Mun Y-C, Lee WS, Chang MH, Park J, Kwon JH, Kim D-W. Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study. Haematologica [Internet]. 2016May31 [cited 2026Nov.17];101(6):717-23. Available from: https://haematologica.org/article/view/7737